AJR ARRS PQI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ito, H.
Right arrow Articles by Minami, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ito, H.
Right arrow Articles by Minami, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.05.0086
AJR 2006; 186:1761-1770
© American Roentgen Ray Society


Original Research

Relationship Between Bone Marrow Edema and Development of Symptoms in Patients With Osteonecrosis of the Femoral Head

Hiroshi Ito1, Takeo Matsuno1 and Akio Minami2

1 Department of Orthopedic Surgery, Asahikawa Medical College, Midorigaoka Higashi 2-1-1-1, Asahikawa 078-8510, Japan.
2 Hokkaido University School of Medicine, Hokkaido, Japan.

Received January 18, 2005; accepted after revision July 6, 2005.

 
Address correspondence to H. Ito (itobiro{at}asahikawa-med.ac.jp).


Abstract
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
OBJECTIVE. The purpose of this study was to determine the significance of risk factors on MR images for predicting the outcome of patients with osteonecrosis of the femoral head.

SUBJECTS AND METHODS. Eighty-three asymptomatic or minimally symptomatic hips in 61 consecutive patients were followed up prospectively. Inclusion criteria included osteonecrosis of the femoral head identified by typical MRI findings, with no radiographic evidence of progression of collapse, and Harris hip score of 85 points or more. Every 3 months, the patients underwent clinical and radiographic examination, and MR images were obtained at 6- to 12-month intervals. Follow-up continued until worsening of hip pain with Harris hip score of less than 70 points or surgery. Asymptomatic hips were followed up for at least 24 months. The mean clinical and radiographic follow-up period after the initial diagnosis was 60 months (range, 3-168 months).

RESULTS. Thirty-six (43%) of the 83 hips were symptomatic at the last follow-up. Bone marrow edema was present in 28 hips (34%) during the follow-up period. Twenty-seven (96%) of the 28 hips were symptomatic, and bone marrow edema significantly correlated with worsening of hip pain (p < 0.0001). The necrotic volume of hips with bone marrow edema was significantly larger than those without bone marrow edema (p < 0.0001). Bone marrow edema was found to be the most significant risk factor for worsening of pain (p < 0.0001).

CONCLUSION. Bone marrow edema strongly correlated with necrotic volume and was the most significant risk factor for worsening of hip pain. A large necrotic volume of 30% or more may be the second useful indicator for predicting future worsening of hip pain.

Keywords: bone marrow • edema • ischemia • MRI • orthopedic surgery • osteonecrosis


Introduction
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Disabling hip pain with progressive collapse is the main complication of nontraumatic osteonecrosis of the femoral head. In studies using MRI, poor results of worsening pain were reported in 23-62% of patients [1-7]. Many factors should be evaluated to predict the outcome of patients with osteonecrosis. The extent and location of the necrotic lesion have been reported to affect the prognosis [1, 2, 5-10]. Several studies have shown that bone marrow edema at the femoral head and neck on MR images was observed in patients with osteonecrosis, and this signal abnormality has been reported to have a strong association with hip pain and risk of radiographic collapse [2-4, 7, 11-18].

Recently, the necrotic volume was reported to be one of the most significant factors for worsening of hip pain [5, 6, 10]. This study prospectively investigated the risk factors on MR images to predict the outcome in patients with osteonecrosis of the femoral head, particularly assessing bone marrow edema, necrotic volume, and their relationship to the occurrence of symptoms.


Subjects and Methods
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Between February 1990 and July 2002, 97 asymptomatic or minimally symptomatic hips in 61 consecutive patients with early-stage nontraumatic osteonecrosis of the femoral head were followed prospectively. These patients were identified by random screening of high-risk groups of patients who underwent corticosteroid therapy or those with asymptomatic or minimally symptomatic hips with contralateral symptomatic hips.

The diagnosis was made from conventional radiographs, MR images, or both. The necrotic lesions of all patients were confirmed by crescent signs of low signal intensity in the weight-bearing portion of the femoral head, bandlike lesions (Figs. 1A, 1B, 1C, 1D and 1E), ringlike lesions with homogeneous or inhomogeneous central areas, diffuse decreased signal intensity with a dark band (Figs. 2A, 2B, 2C, 2D and 2E), or collapse of the femoral head on MR images [11, 18, 19].


Figure 1
View larger version (134K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A —Right femoral head in 48-year-old woman who received high-dose steroid therapy for dermatomyositis. Coronal T1-weighted MR image (TR/TE, 450/17) obtained 12 months after initiation of therapy and 4 weeks after onset of hip pain shows decreased signal intensity in femoral head and neck. Necrotic volume is 29.8%.

 

Figure 2
View larger version (137K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B —Right femoral head in 48-year-old woman who received high-dose steroid therapy for dermatomyositis. Coronal T2-weighted MR image (3,000/102) shows high-signal-intensity bone marrow edema in femoral head and neck.

 

Figure 3
View larger version (157K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1C —Right femoral head in 48-year-old woman who received high-dose steroid therapy for dermatomyositis. Anteroposterior radiograph shows minimum collapse of femoral head. Harris hip score [20] is 93 points.

 

Figure 4
View larger version (157K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1D —Right femoral head in 48-year-old woman who received high-dose steroid therapy for dermatomyositis. Anteroposterior radiograph 3 months after A-C shows radiolucent zone and clear demarcation line.

 

Figure 5
View larger version (164K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1E —Right femoral head in 48-year-old woman who received high-dose steroid therapy for dermatomyositis. Frog-leg lateral radiograph shows progression of collapse. Patient reports right hip pain but refuses surgery. Harris hip score is 48 points.

 

Figure 6
View larger version (142K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2A —Left femoral head of 25-year-old woman who received high-dose steroid therapy for systemic lupus erythematosus. Coronal T1-weighted MR image (TR/TE, 500/17) obtained 18 months after initiation of therapy and 2 weeks after onset of hip pain shows decreased signal intensity in femoral head. Necrotic volume calculated on sequential T1-weighted images is 24.5%.

 

Figure 7
View larger version (139K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2B —Left femoral head of 25-year-old woman who received high-dose steroid therapy for systemic lupus erythematosus. Coronal T2-weighted MR image (3,000/102) shows high-signal-intensity bone marrow edema in femoral head and neck.

 

Figure 8
View larger version (141K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2C —Left femoral head of 25-year-old woman who received high-dose steroid therapy for systemic lupus erythematosus. Frog-leg lateral radiograph appears to show normal findings. Harris hip score [20] is 96 points.

 

Figure 9
View larger version (141K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2D —Left femoral head of 25-year-old woman who received high-dose steroid therapy for systemic lupus erythematosus. Anteroposterior radiograph 12 months after A-C shows radiolucent zone and sclerotic changes in femoral head.

 

Figure 10
View larger version (137K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2E —Left femoral head of 25-year-old woman who received high-dose steroid therapy for systemic lupus erythematosus. Frog-leg lateral radiograph shows progressive collapse of femoral head. Patient reports left hip pain, and femoral transtrochanteric rotational osteotomy is being considered. Harris hip score is 66 points.

 
Clinical evaluation was performed according to the Harris hip-scoring system [20]. Minimally symptomatic hips were defined as those showing occasional or low-grade hip pain and a hip score of 85 points or more. Minimally symptomatic early-stage osteonecrosis was found in 87 hips of 51 patients; 36 patients had bilateral and 15 had unilateral involvement. Asymptomatic osteonecrosis was found in 10 hips of 19 patients with contralateral radiographic advanced osteonecrosis. Of these, 14 hips in 14 patients with bilateral involvement could not be followed up by MRI because the contralateral hip underwent surgery involving metal within 2 years after diagnosis. Surgery included eight femoral osteotomies, three bipolar hemiarthroplasties, and three total hip arthroplasties. These 14 hips were excluded from this analysis because it was not clear whether they showed bone marrow edema over time. The remaining 83 hips in 61 patients were included in this study; the subjects were 20 men and 41 women. Osteonecrosis was idiopathic in six patients, alcohol-induced in seven patients, and high-dose steroid-induced in 48 patients. The mean patient age when the MR images initially revealed necrotic lesions was 35 years (range, 15-74 years).

All MRI examinations were performed on a 1.5-T superconductive unit (Magnetom Vision, Siemens Medical Solutions; or Signa, GE Healthcare). Imaging was performed using a body coil with the patient in the supine position. We obtained the following sequences: coronal and axial T1-weighted spin-echo images (TR range/TE range, 360-600/9-20) and coronal and axial T2-weighted fast spin-echo images (1,800-3,800/90-102) of both hips. The field of view was 30-38 cm. Slice thickness was 4-6 mm with an interslice gap of 0.3-0.5 mm. An average of 8-10 slices were evaluated for each femoral head. Most images were reconstructed using a 256 x 256 data matrix.

Bone marrow edema was defined as an ill-defined area of low signal intensity on T1-weighted images with corresponding high signal intensity on T2-weighted images that involved the femoral head and neck beyond the necrotic zone and extending to intertrochanteric regions [2-4, 7, 11-18]. A well-demarcated arcuate zone of high signal intensity on T2-weighted images surrounding the necrotic area of the femoral head was considered granulation tissue, which was distinguished from bone marrow edema [16, 18]. Hips with reactive edema completely surrounding the necrotic fragment (an extensive double-line sign) that did not extend into the femoral neck were classified as not having bone marrow edema. A subchondral insufficiency fracture of the femoral head was distinguished from osteonecrosis as follows: The shape of the low-intensity band in osteonecrosis on T1-weighted images is usually concave to the articular surface, whereas in a subchondral insufficiency fracture the low-intensity band often parallels the articular surface and has a serpiginous shape that does not circumscribe lesions; patients with a subchondral insufficiency fracture generally include elderly women with osteoporosis who are often obese; and the patient's pain usually has an acute onset [21].

The necrotic volume was measured on the first abnormal MR images and the percentage of involvement of the femoral head was measured. MR images were digitized with a scanner using image software (Photoshop, Adobe Systems). To calculate the necrotic lesions of the entire femoral head on each image, an image analysis software package was used (NIH Image, National Institutes of Health). Initially, the circumferences of the femoral head and of the necrotic area as seen on sequential T1-weighted coronal images were outlined using a nonpermanent fine-tip marker (Figs. 3A, 3B). The software program measures the area of the outlined structure on each particular slice. The necrotic volume was calculated by the integration of each sequential coronal image. The measured areas were multiplied by the sum of the slice and interslice thicknesses of the MR image to determine the volume of the outlined structures. After the volume of the necrotic segment and the volume of the entire femoral head were determined, the percentage of femoral head involvement was calculated.


Figure 11
View larger version (134K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3A —Measuring necrotic volume of femoral head using NIH Image software (National Institutes of Health). Initially, circumference of femoral head (dotted line) as seen on each sequential T1-weighted coronal image is outlined using a nonpermanent fine-tip marker.

 

Figure 12
View larger version (133K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3B —Measuring necrotic volume of femoral head using NIH Image software (National Institutes of Health). Then circumference of necrotic area (dotted line) is outlined.

 

The necrotic locations on T1-weighted central coronal images were classified as type A, type B, or type C using the criteria described by Sugano et al. [1]. Type A lesions occupy the medial one third or less of the weight-bearing portion of the acetabulum; type B, the medial two thirds or less of the weight-bearing portion; and type C, more than two thirds of the weight-bearing portion (Fig. 4).


Figure 13
View larger version (7K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4 —Classification of necrotic locations according to criteria of Sugano et al. [1]: lesions occupying medial one third or less (type A), two thirds or less (type B), or more than two thirds (type C) of weight-bearing portion.

 
Radiographically, anteroposterior and Lauenstein lateral (lateral view of the femoral head and neck) views were obtained at each examination. Independent of the MR images, the radiographic stage was determined according to the classification of Steinberg et al. [9]: stage I, normal findings on radiography; stage II, cystic and sclerotic changes; stage III, subchondral radiolucency or crescent sign; stage IV, flattening of the femoral head; stage V, joint space narrowing; and stage VI, advanced degenerative change. Initially, 55 hips were classified as stage I, 15 as stage II, and 13 as stage III. No collapse was found in stage I and stage II hips, but all 13 stage III hips presented collapse on initial MR images. Radiographic factors include the necrotic stage, progression of staging, and initial 2D percentage of involvement of necrotic lesions seen on the anteroposterior view. The 2D percentage of necrotic lesions was calculated using the same image analysis software as described previously. The MR images and radiographs were reviewed and interpreted by consensus of the experts on diagnosis of this disease, excluding residents, in a clinical conference. The observers were not blinded to clinical and radiographic assessments, and intra- or interobserver variability studies were not performed.

All patients were followed up prospectively by clinical evaluation, conventional radiography, and MRI. Every 3 months, the patients underwent clinical and radiographic examination, and MR images were obtained at 6- to 12-month intervals. Follow-up continued until the patient became symptomatic or underwent surgery. Symptomatic patients were defined as those complaining of mild or more severe pain with a hip score of less than 70 points to simplify the clinical outcome. Asymptomatic hips were followed up for at least 24 months. The mean clinical and radiographic follow-up period after the initial diagnosis was 60 months (range, 3-168 months), and the mean MRI follow-up period was 48 months (range, 0-168 months). Informed consent was obtained before the patients were enrolled in this study.

Statistical analyses of the radiographic data were performed using StatView statistical software (SAS Institute). Sex, age, etiologic factors, and various factors on radiographs and MR images were analyzed. Multivariate regression analysis was performed using the Cox proportional hazards model to evaluate various factors. The Cox model was applied to each variable to separately screen for possible risk factors affecting survival, and then the selected possible risk factors were examined together to determine their contribution to survival. Based on the final model, a p value was calculated for each parameter. A probability value of less than 0.05 was considered significant. The cumulative rates of survival were calculated, with a hip score of less than 70 points or the need for surgery as the end point.


Results
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Thirty-six (43%) of the 83 hips were symptomatic at the latest follow-up examination. The average Harris hip score [20] was initially 96 points (range, 85-100 points) and finally 78 points (range, 28-100 points). Correlation of the initial and final radiographic stages is summarized in Table 1. All 36 symptomatic hips showed radiographic collapse. Progression of staging was found in 42 (51%) hips. New collapse developed in 26 (52%) of 50 hips that were initially classified as stage I or stage II without collapse. At the time of follow-up, none of 44 hips without collapse (final stage, I or II) were symptomatic, whereas 36 of 39 hips with collapse (final stage, III, IV, or V) were symptomatic (chi-square test, p < 0.0001). Twenty-two of these 36 symptomatic hips had undergone surgery: intertrochanteric varus osteotomy (n = 5), transtrochanteric anterior rotational osteotomy (n = 4), bipolar prosthesis (n = 5), and total hip arthroplasty (n = 8).


View this table:
[in this window]
[in a new window]

 
TABLE 1: Correlation of Initial and Final Radiographic Stages

 

Bone marrow edema was present in 28 (34%) hips during the follow-up period. Twenty-one of these 28 hips showed bone marrow edema on the diagnostic MR images in which osteonecrosis was initially identified. Seven hips did not show bone marrow edema on those images. The average period between initial diagnosis of osteonecrosis and development of bone marrow edema in these seven hips was 16 months (range, 6-24 months). Bone marrow edema was typically identified around the time of onset of hip pain. Bone marrow edema was seen at stage I in three (11%) hips, stage II in five (18%) hips, stage III in 18 (64%) hips, and stage IV in two (7%) hips. Twenty-seven (96%) of these 28 hips were symptomatic at the final follow-up evaluation (Table 2), and bone marrow edema significantly correlated with the symptoms (chi-square test, p < 0.0001). All 21 hips that showed bone marrow edema on initial diagnostic MR images for osteonecrosis were symptomatic at the final follow-up, which was significantly higher than the 62 hips without bone marrow edema on those images, of which 15 (24%) hips were symptomatic (chi-square test, p < 0.0001). The radiographic stage at the time of follow-up of the 28 hips with bone marrow edema was stage III in 18 hips, stage IV in seven hips, and stage V in three hips, which was significantly more advanced than the 55 hips without bone marrow edema during follow-up (chi-square test, p < 0.0001).


View this table:
[in this window]
[in a new window]

 
TABLE 2: Relationship Between Bone Marrow Edema and Various Factors

 

The average necrotic volume was 28.5% (range, 3.0-70.2%): 39.5% ± 13.3% (SD) in the 36 symptomatic hips and 19.9% ± 16.5% in the 47 asymptomatic hips. In 35 hips with a large necrotic volume of 30% or more, 25 (71%) hips were symptomatic at the final follow-up, which was significantly higher than 48 hips with a small necrotic volume of less than 30%; only 11 (23%) of these hips were symptomatic (chi-square test, p < 0.0001). The necrotic volume of hips with bone marrow edema was significantly larger than in those hips without bone marrow edema (Mann-Whitney U test, p < 0.0001). The radiographic stage at the time of follow-up had significantly progressed in hips with bone marrow edema (chi-square test, p < 0.0001).

The average necrotic lesion on T1-weighted central coronal images was 28.2% (range, 0-75.9%): 38.6% ± 13.4% in the 36 symptomatic hips and 20.2% ± 13.7% in the 47 asymptomatic hips. According to the necrotic location, 18 hips were classified as type A, 13 hips as type B, and 52 hips as type C lesions. In relation to the classification of MR images, none of the 18 type A hips, five (38%) of the 13 type B hips, and 31 (60%) of the 52 type C hips were symptomatic at the final follow-up. In radiographic assessment, the average involvement of lesions was 19.4% (range, 0-60.0%) at final follow-up.

With a hip score of less than 70 points or the need for surgery as the end point, the cumulative rates of survival were 72.3% (95% confidence interval [CI], 67.4-77.2%) at 1 year, 61.4% (56.1-66.7%) at 2 years, 57.3% (51.8-62.8%) at 5 years, and 54.7% (48.9-60.5%) at 10 years. Figure 5 shows the cumulative rate of survival comparing hips with and those without bone marrow edema on diagnostic MR images in which osteonecrosis was initially identified. No significant factors were found with application of the Cox model in age (p = 0.5564). Male sex (p = 0.0054), alcohol-related cause (p = 0.0086), initial stage at radiography (p = 0.0005), and percentage of necrotic lesions (p < 0.0001) were possible risk factors. On MR images, the presence of bone marrow edema (p < 0.0001), the percentage of necrotic volume (p < 0.0001), the percentage on coronal images of central necrotic lesions (p < 0.0001), and the necrotic location type (p = 0.0008) were also possible risk factors. When these eight possible factors were analyzed together using the Cox model, the presence of bone marrow edema (p < 0.0001) was found to be the most significant risk factor.


Figure 14
View larger version (5K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5 —Line graph shows cumulative rate of survival comparing hips with (dotted line) and those without (solid line) bone marrow edema on diagnostic MR images in which osteonecrosis was initially identified.

 

Discussion
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Previous studies reported that diffuse signal abnormalities in the marrow of the femoral head and neck were found in early-stage osteonecrosis [2-4, 7, 11-18]. These abnormal signals consisted of decreased signal intensity on T1-weighted images and a matching increase in signal intensity on T2-weighted images, indicating bone marrow edema of elevated free-water content. Some authors have proposed that bone marrow edema might be the initial MRI finding in early osteonecrosis [12, 13]. However, recent studies have reported that the initial MRI finding of early osteonecrosis is a bandlike pattern, that bone marrow edema is not the initial MRI finding after the onset of hip pain, and that bone marrow edema correlated highly with the subsequent collapse of the femoral head [2, 4, 15-18]. Bandlike lesions, ringlike lesions, or diffuse decreased signal intensity with a dark band, with or without collapse on MR images, was the initial MR finding in most cases in our study, which was consistent with those recent studies. Separately, the most significant factor for clinical worsening of hip pain in our study was the occurrence of bone marrow edema during the follow-up period.

Using computer software, we measured the necrotic volume on sequential coronal MR images and found that the necrotic volume was one possible risk factors to predict the outcome. The necrotic volume and bone marrow edema might be important factors; however, some hips with a large necrotic volume remained asymptomatic without progressive collapse, and some hips with a moderate necrotic volume became symptomatic with progressive collapse. Therefore, the necrotic volume measured on initial diagnostic MR images may be the second useful indicator to predict the outcome.

The mechanism that produces bone marrow edema remains unknown, although some investigators have speculated that bone marrow edema could be a secondary reaction to subchondral fractures arising from mechanical stress [2, 4, 15-18]. Koo et al. [3] proposed that edema adjacent to necrosis is a secondary reaction to ischemia and that localized edema is a secondary phenomenon after an ischemic attack in the area surrounding the necrotic region, such as brain ischemia. In this explanation, however, it is not clear why all necrotic femoral heads do not always show bone marrow edema in the course of the disease, and why the time discrepancy between the occurrence of necrosis and the occurrence of bone marrow edema is not consistent.

Kubo et al. [2] suggested that bone marrow edema may be an inflammatory change in the reparative process after collapse of the femoral head because it was detected most frequently in stage III hips (classification of Steinberg et al. [9]) and because two stage II hips with bone marrow edema collapsed and progressed to stage III within 6 months after the MR examination. Sakai et al. [16] reported that extralesional reactive changes with diffuse enhancement were detected along the boundary most frequently in stage III hips in the form of dilated vessels and bone marrow edema, which may represent an inflammatory change in the reactive process after collapse of the femoral head. They proposed that even if a hip has not radiologically collapsed, the detection of bone marrow edema on MRI might indicate that the femoral head has begun to collapse at the microscopic level. Kim et al. [15] reported that bone marrow edema on MR images was only detectable when the subchondral fracture was just beginning. They believed that a bone marrow edema pattern appeared as a secondary reaction to subchondral fracture.


Figure 15
View larger version (133K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6A —Left femoral head of 16-year-old girl who received steroid therapy for systemic lupus erythematosus. Coronal T1-weighted MR image (TR/TE, 360/9) obtained 12 months after initiation of therapy and 4 weeks after onset of hip pain shows a bandlike hypointense zone in femoral head. Necrotic volume is 38.5%.

 


Figure 16
View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6B —Left femoral head of 16-year-old girl who received steroid therapy for systemic lupus erythematosus. Coronal T2-weighted MR image (3,800/102) shows bandlike hypointense zone in femoral head. Bone marrow edema is not found. Harris hip score [20] is 88 points.

 


Figure 17
View larger version (135K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6C —Left femoral head of 16-year-old girl who received steroid therapy for systemic lupus erythematosus. Coronal T1-weighted MR image (500/20) obtained 5 years after A and B shows almost same necrotic area in femoral head. No collapse is found. Bone marrow edema was not found during this period.

 


Figure 18
View larger version (137K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6D —Left femoral head of 16-year-old girl who received steroid therapy for systemic lupus erythematosus. Frog-leg lateral radiograph 5 years after A and B appears to show normal findings. Patient reports no worsening of hip pain during this period. Harris hip score is 91 points.

 
Iida et al. [4] reported that initial abnormal findings on radiography were slight in 13 hips with bone marrow edema, but 11 (85%) of 13 hips subsequently progressed to advanced osteonecrosis. They concluded that bone marrow edema should be considered a marker for potential progression to advanced osteonecrosis. These studies coincide with our study. The final radiographic stage of the 28 hips that showed bone marrow edema was significantly advanced compared with those without bone marrow edema. Bone marrow edema might represent an inflammatory change in the reactive process during the progression of collapse of the femoral head and might be an unfavorable sign for the prognosis.

On the other hand, Koo et al. [3] reported no significant difference between the collapse rate in hips associated with edema (10/12) and the remaining hips not associated with edema (19/25). They also reported that bone marrow edema of the proximal femur was strongly associated with pain; however, several cases did not show collapse after edema for a considerable period, and pain was alleviated with the resolution of bone marrow edema despite radiographic evidence of collapse. Ficat and Arlet [22] reported that bone marrow edema can occur from intramedullary venous stasis without collapse in patients with osteonecrosis, although the reason for this difference is not clear.

One possible reason is the different treatments indicated for osteonecrosis of the femoral head: We did not perform core decompression, preferring femoral osteotomy. We believe that the most important concept in the treatment of osteonecrosis of the femoral head is to remove the necrotic lesions from the weight-bearing portions of the hip joint [8]. The lesions of the weight-bearing portions should be replaced with normal articular cartilage and subchondral bone by femoral osteotomy. Although core decompression is reportedly an effective procedure [22], studies have questioned its effectiveness because of its high failure rate [23, 24].

Subchondral focal lesions are likely to be overlooked because bone marrow edema develops around the surrounding living bone and may obscure subchondral focal abnormalities on MR images (Fig. 2B). Mirowitz et al. [25] reported that bone marrow abnormalities can be accurately evaluated on fat-suppressed T2-weighted and STIR images. Iida et al. [4] reported that the high signal intensity of normal fat is decreased on STIR images, and small focal lesions of osteonecrosis associated with bone marrow edema can easily be detected. It is often difficult to detect focal abnormalities with bone marrow edema on T2-weighted images; STIR images are more useful for evaluating bone marrow edema with osteonecrosis. We agree with these comments that fat-suppressed T2-weighted or STIR images should be evaluated for bone marrow edema. We now routinely obtain STIR images for evaluation, although we did not do so during this study, for which we evaluated bone abnormalities only on T1- and T2-weighted images at 6- to 12-month intervals, which was one weakness of this study. It is possible that we underestimated the incidence of bone marrow edema.

Use of a body coil instead of a local coil was another potential limitation of our study. The resolution achievable with adequate signal-to-noise ratio might not have been enough to identify accurately the volume of involvement or the presence of subtle focal subchondral lesions or collapse. Other limitations were that the observers were not blinded for clinical and radiographic assessments, and intra- or interobserver variability studies were not done.

The presence or absence of bone marrow edema on initial diagnostic MR images, not just the development of bone marrow edema during follow-up, is important. Ideally, prognostication should be based on the earliest available data. If the necrotic volume measured on the initial MR images can almost predict the outcome and the development of bone marrow edema 1 or 2 years later, then the volume indicator is better clinically because it gives an earlier indication and is cheaper. Measuring the necrotic volume requires only one MRI sequence, not sequential sequences. However, if at the time of onset the patient's hip pain is not severe (Figs. 1A, 1B, 1C, 1D and 1E and 2A, 2B, 2C, 2D and 2E), we can prognosticate worsening of hip pain by the presence of bone marrow edema on simultaneous MR images. If bone marrow edema is not present at that time, the hip pain may possibly not progressively deteriorate, at least for a while (Figs. 6A, 6B, 6C and 6D). Follow-up with MRI at 6-month intervals would be recommended for such patients to detect the occurrence of bone marrow edema, which is the most significant risk factor for worsening of hip pain. If the patient refuses follow-up MRI because of its cost, the presence or absence of bone marrow edema and the necrotic volume measured on the initial diagnostic MR images may be the second useful indicators for prognostication. A necrotic volume of 30% or more indicates a high likelihood of future worsening of hip pain.

In conclusion, bone marrow edema strongly correlates with necrotic volume and worsening of hip pain in patients with osteonecrosis of the femoral head. We believe that bone marrow edema represents the occurrence of collapse of the femoral head and is an unfavorable sign in disease prognosis. Assessment of the presence or absence of bone marrow edema may be most useful to foretell worsening of hip pain for patients at the time of onset of hip pain. A large necrotic volume of 30% or more measured on initial diagnostic MR images may be the second useful indicator to predict future worsening of hip pain.


References
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 

  1. Sugano N, Ohzono K, Masuhara K, Takaoka K, Ono K. Prognostication of osteonecrosis of the femoral head in patients with systemic lupus erythematosus by magnetic resonance imaging. Clin Orthop 1994; 305:190 -199
  2. Kubo T, Yamazoe S, Sugano N, et al. Initial MRI findings of non-traumatic osteonecrosis of the femoral head in renal allograft recipients. Magn Reson Imaging 1997;15 : 1017-1023[CrossRef][Medline]
  3. Koo KH, Ahn IO, Kim R, et al. Bone marrow edema and associated pain in early stage osteonecrosis of the femoral head: prospective study with serial MR images. Radiology 1999;213 : 715-722[Abstract/Free Full Text]
  4. Iida S, Harada Y, Shimizu K, et al. Correlation between bone marrow edema and collapse of the femoral head in steroid-induced osteonecrosis. AJR 2000; 174:735 -743[Abstract/Free Full Text]
  5. Nishii T, Sugano N, Ohzono K, Sakai T, Sato Y, Yoshikawa H. Significance of lesion size and location in the prediction of collapse of osteonecrosis of the femoral head: a new three-dimensional quantification using magnetic resonance imaging. J Orthop Res2002; 20:130 -136[CrossRef][Medline]
  6. Ito H, Matsuno T, Omizu N, Aoki Y, Minami A. Mid-term prognosis of non-traumatic osteonecrosis of the femoral head. J Bone Joint Surg Br 2003; 85:796 -801
  7. Radke S, Kirschner S, Seipel V, Rader C, Eulert J. Magnetic resonance imaging criteria of successful core decompression in avascular necrosis of the hip. Skeletal Radiol2004; 33:519 -523[Medline]
  8. Merle D'Aubign R, Postel M, Mazabraud A, Massias P, Gueguen J. Idiopathic necrosis of the femoral head in adults. J Bone Joint Surg Br 1965; 47:612 -633
  9. Steinberg ME, Hayken GD, Steinberg DR. A quantitative system for staging avascular necrosis. J Bone Joint Surg Br1995; 77:34 -41
  10. Steinberg ME, Bands RE, Parry S, Hoffman E, Chan T, Hartman KM. Does lesion size affect the outcome in avascular necrosis? Clin Orthop 1999; 367:262 -271
  11. Mitchell DG, Rao VM, Dalinka MK, et al. Femoral head avascular necrosis: correlation of MR imaging, radiographic staging, radionuclide imaging, and clinical findings. Radiology1987; 162:709 -715[Abstract/Free Full Text]
  12. Turner DA, Templeton AC, Selzer PM, Rosenberg AG, Petasnick JP. Femoral capital osteonecrosis: MR finding of diffuse marrow abnormalities without focal lesions. Radiology 1989;171 : 135-140[Abstract/Free Full Text]
  13. Li KC, Hiette P. Contrast-enhanced fat saturation magnetic resonance imaging for studying the pathophysiology of osteonecrosis of the hips. Skeletal Radiol 1992;21 : 375-379[Medline]
  14. Vande Berg BC, Malghem JJ, Lecourvet FE, Jamart J, Maldague BE. Idiopathic bone marrow edema lesions of the femoral head: predictive value of MR imaging findings. Radiology 1999;212 : 527-535[Abstract/Free Full Text]
  15. Kim YM, Oh HC, Kim HJ. The pattern of bone marrow oedema on MRI in osteonecrosis of the femoral head. J Bone Joint Surg Br 2000; 82:837 -841
  16. Sakai T, Sugano N, Nishii T, Haraguchi K, Ochi T, Ohzono K. MR findings of necrotic lesions and the extralesional area of osteonecrosis of the femoral head. Skeletal Radiol 2000;29 : 133-141[CrossRef][Medline]
  17. Fujioka M, Kubo T, Nakamura F, et al. Initial changes of non-traumatic osteonecrosis of femoral head in fat suppression images: bone marrow edema was not found before the appearance of band patterns. Magn Reson Imaging 2001;19 : 985-991[CrossRef][Medline]
  18. Huang GS, Chan WP, Chang YC, Chang CY, Chen CY, Yu JS. MR imaging of bone marrow edema and joint effusion in patients with osteonecrosis of the femoral head: relationship to pain. AJR2003; 181:545 -549[Abstract/Free Full Text]
  19. Totty WG, Murphy WA, Ganz WI, Kumar B, Daum WJ, Siegel BA. Magnetic resonance imaging of the normal and ischemic femoral head. AJR 1984; 143:1273 -1280[Abstract/Free Full Text]
  20. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fracture: treatment by mold arthroplasty. J Bone Joint Surg Am 1969; 51:737 -755[Abstract/Free Full Text]
  21. Motomura G, Yamamoto T, Miyanishi K, Shirasawa K, Noguchi Y, Iwamoto Y. Subchondral insufficiency fracture of the femoral head and acetabulum: a case report. J Bone Joint Surg Am2002; 84:1205 -1209[Free Full Text]
  22. Ficat RP, Arlet J. Necrosis of the femoral head. In: Hungerford DS, ed. Ischemia and necrosis of bone. Baltimore, MD: Williams & Wilkins, 1980:53 -74
  23. Koo KH, Kim R, Ko GH, Song HR, Jeong ST, Cho SH. Preventing collapse in early osteonecrosis of the femoral head: a randomised clinical trial of core decompression. J Bone Joint Surg Br1995; 77:870 -874
  24. Learmonth ID, Maloon S, Dall G. Core decompression for early atraumatic osteonecrosis of the femoral head. J Bone Joint Surg Br 1990; 72:387 -390
  25. Mirowitz SA, Apicella P, Reinus WR, Hammerman AM. MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images. AJR 1994;162 : 215-221[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Am Acad Orthop SurgHome page
A. V. Korompilias, A. H. Karantanas, M. G. Lykissas, and A. E. Beris
Transient Osteoporosis
J. Am. Acad. Ortho. Surg., August 1, 2008; 16(8): 480 - 489.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ito, H.
Right arrow Articles by Minami, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ito, H.
Right arrow Articles by Minami, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS